Functional protein expression
Antibody research support
Mouse hybridoma sequencing
Recombinant protein production
Contract antibody research
Antibody and reagent sales
List of antibody products
ELISA kit for PTX3 measurement
Product specifications and distributors
Our general experimental protocols
Message from CEO
Board Member Profile
Other IR Materials
Timely Disclosure Information
General Stock Information
Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at Digestive Disease Week 2007
Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The 51st Annual General Assembly and Scientific Meeting of Japan College of Rheumatology
Development of Cystatin SN as a new diagnostic marker for colon cancer Reported at The 93rd Annual Meeting of the Japanese Society of Gastroenterology
Research progress regarding the " Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The American college of cardiology held on March 24-27th, 2007 in New Orleans.
Research progress regarding the "Vascular Injury marker Pentraxin 3(PTX3)" will be presented at The 71st Annual Scientific Meeting of the Japanese Circulation Society held on March 15-17th, 2007 in Kobe.
Our Collaboration Research results regarding "The Vascular Injury Marker PTX3" and "Research in Nuclear Hormone Receptors" will be presented at the 96th Annual Pathology Meeting.
Pentraxin 3 levels indicate unstable angina [Reuters - Therapeutics Daily]
Our scientific article using Perseus Proteomics human ELISA system "Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris" was just published.
Perseus Proteomics and Chugai Pharmaceutical reach purchase and sales agreement on glypican-3 therapeutic antibody.